Composition for inhibition of cathepsin K

Details for Australian Patent Application No. 2006302797 (hide)

Owner Merck Frosst Canada Ltd Merck Sharp & Dohme Corp.

Inventors Black, Cameron; Daifotis, Anastasia; Ince, Basil Avery; Stoch, Selwyn Aubrey

Agent Spruson & Ferguson

Pub. Number AU-B-2006302797

PCT Pub. Number WO2007/046842

Priority 60/657,982 02.03.05 US

Filing date 24 February 2006

Wipo publication date 26 April 2007

Acceptance publication date 2 February 2012

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/66 (2006.01) - Phosphorus compounds

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2007/046842 Priority application(s): WO2007/046842

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Frosst Canada Ltd.; Merck Sharp & Dohme Corp.

2 February 2012 Application Accepted

  Published as AU-B-2006302797

31 May 2012 Standard Patent Sealed

4 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Frosst Canada Ltd; Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006302801-Treatment of substrates for improving ink adhesion to the substrates

2006302794-New live virus vaccines